This review has reported extensively on studies that have used different experimental approaches, ranging from molecular assays to metabolomics and cytological assessment, as well as different biomarkers, ranging from Aβ and tau proteins to oral microbiome, toward AD investigation. Here, MAPT is linked to Alzheimer disease.